6 results
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
Clostridium Dificile ... #CDifficile #Infection ... #Pharmacology # ... #Clindamycin #Clostridium ... #Table #Comparison
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Episode #Pharmacology ... #CDifficile #IDSA2017 ... #Adjunct #Antibiotics
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... if MIC<0.12 ug/ml ... Therapy for Treating Clostridium ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... chew, or crush tablet ... suspension 4–6 mL ... opportunistic #infections #HIVAIDS ... #pharmacology
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
of the Primary Clostridium ... difficile infection ... treatment #management #pharmacology ... #idsa #table
IDSA Recommended Dosages of Antimicrobial Agents Administered by the Intraventricular Route
Amikacin - 5–50 mg
Amphotericin B -
IDSA Recommended ... Intraventricular #antibiotics ... #dosing #pharmacology ... ventriculitis #table ... #idsa